Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice

BACKGROUND: Stroke is a major cause of morbidity and mortality. Stroke is complicated by brain edema and blood-brain barrier (BBB) disruption, and is often accompanied by increased release of arginine-vasopressin (AVP). AVP acts through V1a and V2 receptors to trigger hyponatremia, vasospasm, and pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeynalov, Emil, Jones, Susan M., Seo, Jeong-Woo, Snell, Lawrence D., Elliott, J. Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537303/
https://www.ncbi.nlm.nih.gov/pubmed/26275173
http://dx.doi.org/10.1371/journal.pone.0136121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537303/
https://www.ncbi.nlm.nih.gov/pubmed/26275173
http://dx.doi.org/10.1371/journal.pone.0136121

Ejemplares similares